1. Home
  2. PCT vs MIRM Comparison

PCT vs MIRM Comparison

Compare PCT & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PureCycle Technologies Inc.

PCT

PureCycle Technologies Inc.

HOLD

Current Price

$9.14

Market Cap

1.8B

Sector

Utilities

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$79.90

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCT
MIRM
Founded
2015
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Environmental Services
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
3.4B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
PCT
MIRM
Price
$9.14
$79.90
Analyst Decision
Buy
Strong Buy
Analyst Count
3
11
Target Price
$13.67
$92.45
AVG Volume (30 Days)
4.0M
802.1K
Earning Date
11-06-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,660,000.00
$471,794,000.00
Revenue This Year
N/A
$53.78
Revenue Next Year
$707.73
$19.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
53.66
52 Week Low
$5.40
$36.88
52 Week High
$17.37
$81.70

Technical Indicators

Market Signals
Indicator
PCT
MIRM
Relative Strength Index (RSI) 49.41 67.61
Support Level $7.43 $63.23
Resistance Level $9.50 $66.77
Average True Range (ATR) 0.61 3.70
MACD 0.15 1.62
Stochastic Oscillator 71.06 84.91

Price Performance

Historical Comparison
PCT
MIRM

About PCT PureCycle Technologies Inc.

PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: